Per‐ and polyfluoroalkyl substances and cardiometabolic diseases: A review
Basic & Clinical Pharmacology & Toxicology · 2024-01 · 134 (1) · 141-152
DOI: 10.1111/bcpt.13949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 22.10.2023. Verfasst von Tessa Schillemans und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Adverse Outcome Pathways, Cardiovascular Diseases, Environmental Pollutants. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Research Council, Vetenskapsrådet.
Abstract (Originalsprache)
Per‐ and polyfluoroalkyl substances (PFAS) are a group of persistent and widespread environmental pollutants that represent a high concern for human health. They have been shown to be associated with several important physiological processes such as lipid metabolism and the immune system. Consequently, PFAS are suspected to play a role in cardiometabolic disease development. However, the evidence regarding associations between PFAS and overt cardiovascular disease and type 2 diabetes remains limited and inconsistent. To address this, we conducted a review of the epidemiological evidence. A deeper understanding of potential underlying molecular mechanisms may help to explain inconsistencies in epidemiological findings. Thus, to gain more mechanistic insight, we also summarized evidence from omics and laboratory studies into an adverse outcome pathway framework. Our observations indicate the potential for associations of PFAS with multiple molecular pathways that could have opposite associations with disease risk, which could be further modified by mixture composition, lifestyle factors or genetic polymorphisms. This identifies the need for exposome studies considering mixture effects, the use of multi‐omics data to gain insight in relevant pathways and the integration of epidemiological and laboratory studies to enhance mechanistic understanding and causal inference. Improved comprehension is essential for environmental health risk assessments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Instituto de Salud Global de Barcelona (ISGlobal), Barcelona, Spain.
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
ORCID-Profile: Tessa Schillemans, Agneta Åkesson
Förderung
- Swedish Research Council
- Vetenskapsrådet
Zitieren
APA
Schillemans, T., Donat-Vargas, C., & Åkesson, A. (2024). Per‐ and polyfluoroalkyl substances and cardiometabolic diseases: A review. Basic & Clinical Pharmacology & Toxicology, 134(1), 141-152. https://doi.org/10.1111/bcpt.13949
Vancouver
Schillemans T, Donat-Vargas C, Åkesson A. Per‐ and polyfluoroalkyl substances and cardiometabolic diseases: A review. Basic & Clinical Pharmacology & Toxicology. 2024;134(1):141-152. doi:10.1111/bcpt.13949
BibTeX
@article{Schillemans2024,
author = {Schillemans, Tessa and Donat-Vargas, Carolina and Åkesson, Agneta},
title = {Per‐ and polyfluoroalkyl substances and cardiometabolic diseases: A review},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
volume = {134},
number = {1},
pages = {141--152},
doi = {10.1111/bcpt.13949}
}
EUVIMED